Who may be a candidate?
Women who suffer most from the following symptoms of heavy menstrual bleeding may be candidates for the NovaSure procedure
- Heavy menstrual bleeding severely impacts their emotional well-being, greatly interferes with their lifestyle/activities and can negatively impact their relationships
- Patients are concerned about (and avoid) doing any exercise during their period
- They experience multiple severe symptoms including painful cramps, headaches, depression/moodiness, heavy bleeding, excessive fatigue and bloating
- Patients miss more than eight days of work per year due to their heavy bleeding
The procedure is contraindicated for use in:
- A patient who is pregnant or who wants to become pregnant in the future. Pregnancies following ablation can be dangerous for both mother and fetus
- A patient with known or suspected endometrial carcinoma (uterine cancer) or pre-malignant conditions of the endometrium, such as unresolved adenomatous hyperplasia
- A patient with any anatomic condition (e.g., history of previous classical cesarean section or transmural myomectomy) or pathologic condition (e.g., long-term medical therapy) that could lead to weakening of the myometrium
- A patient with active genital or urinary tract infection at the time of the procedure (e.g., cervicitis, vaginitis, endometritis, salpingitis, or cystitis)
- A patient with an intrauterine device (IUD) currently in place
- A patient with a uterine cavity length less than 4 cm. The minimum length of the electrode array is 4 cm. Treatment of a uterine cavity with a length less than 4 cm will result in thermal injury to the endocervical canal.
- A patient with a uterine cavity width less than 2.5 cm, as determined by the WIDTH dial of the disposable device following device deployment
- A patient with active pelvic inflammatory disease
You may also want to review a full list of the risks and benefits with your patient.
Get the conversation started
It’s not always easy to identify those patients who may be appropriate candidates for endometrial ablation and the NovaSure procedure. Often women consider their heavy bleeding as normal, instead of a serious medical condition. Some are embarrassed to talk about the discomfort and disruption it causes in their lives. You could begin a conversation with patients who you feel may be uncomfortable talking about their symptoms by asking a few of these simple questions:
- Do your periods affect your quality of life
- Are your periods heavy or do they last a long time
- Would your quality of life improve if there were a way to decrease or potentially eliminate your heavy periods
- Do your heavy periods affect your social, athletic or sexual activities, or cause you to miss work
- Do you change protection frequently or carry large quantities of feminine products and/or a change of clothes
- Do your heavy periods cause anxiety, PMS or pain
You may also want to review these questions with your staff to help them identify those patients affected by heavy menstrual bleeding.
Educate your patients about the NovaSure procedure
In addition to extensive after-sales support, along with a highly visible direct-to-patient marketing program, Hologic has developed extensive patient education materials. You can include these in your waiting area or have staff provide them to patients as they are waiting for their appointments. You can also take advantage of our professionally created materials to help generate awareness of your endometrial ablation capabilities.
Simply visit our online Patient Outreach Toolkit and register to order—or download—ready-to-print materials to support your patient education and marketing program. These include:
- Patient brochures
- Online tools, including our new website designed just for patients
- Print and radio advertising copy
- Digital and social media marketing tools
- Seminar tools
- Guides to measure success
- Referring physician outreach letters
Now that I’ve had the NovaSure
procedure, I have a new life!
Janelle Shaw, NovaSure Patient
- Hologic, Inc. Data on file; 2004-2018. Based on units shipped from 2004-2018.
IMPORTANT SAFETY INFORMATION
NovaSure® endometrial ablation is for premenopausal women with heavy periods due to benign causes who are finished childbearing. Pregnancy following the NovaSure procedure can be dangerous. The NovaSure procedure is not for those who have or suspect uterine cancer; have an active genital, urinary or pelvic infection; or an IUD. NovaSure endometrial ablation is not a sterilization procedure. Rare but serious risks include, but are not limited to, thermal injury, perforation and infection. Temporary side effects may include cramping, nausea, vomiting, discharge and spotting. Inform patients to contact you if they experience a possible side effect related to use of this product. For detailed benefit and risk information, please consult the IFU.